Selected model input parameters for the analysis of second-line CAR-T in late relapse patients
Inputs: outcome probabilities . | Base case . | Sensitivity analysis range . | Monte Carlo distribution . | References . |
---|---|---|---|---|
Proportion of RR-DLBCL patients with primary refractory/early relapsed disease | 0.65 | 0.50-0.80 | β | 1,32,33 |
Salvage chemoimmunotherapy as a bridge to auto-SCT in second-line setting in late relapse patients | ||||
Clinical outcomes | ||||
EFS rate at 3 y | 0.45 | 0.35-0.70 | β | 1 |
OS rate at 3 y | 0.52 | 0.32-0.75 | β | 1 |
Overall response rate | 0.88 | 0.70-0.95 | β | 1 |
Inputs: outcome probabilities . | Base case . | Sensitivity analysis range . | Monte Carlo distribution . | References . |
---|---|---|---|---|
Proportion of RR-DLBCL patients with primary refractory/early relapsed disease | 0.65 | 0.50-0.80 | β | 1,32,33 |
Salvage chemoimmunotherapy as a bridge to auto-SCT in second-line setting in late relapse patients | ||||
Clinical outcomes | ||||
EFS rate at 3 y | 0.45 | 0.35-0.70 | β | 1 |
OS rate at 3 y | 0.52 | 0.32-0.75 | β | 1 |
Overall response rate | 0.88 | 0.70-0.95 | β | 1 |